Novo Nordisk’s CagriSema delivers strong Phase 3 results across REIMAGINE diabetes trials

Lilly’s oral GLP-1 drug Orforglipron outperforms Semaglutide in phase 3 diabetes trial

Based on the cumulative data from ACHIEVE-1 through ACHIEVE-5, Lilly plans to submit orforglipron for FDA approval for the treatment of type 2 diabetes by the end of the second quarter

DENSTAR project launched to fast-track dengue vaccine licensure in Africa

Dengue, a mosquito-borne viral disease, is emerging as a growing public health threat across Africa

Lupin Manufacturing Solutions appoints Eduardo Jule as Chief Commercial Officer

Veteran pharma and biotech executive brings over 20 years of commercial leadership experience to support LMS's global CDMO and API growth strategy

Novo Nordisk's Zenagamtide shows strong HbA1c and weight loss benefits in phase II trial

Investigational once-weekly GLP-1 and amylin receptor agonist achieves up to 14.6% weight loss and significant blood sugar reductions

Lupin secures U.S. FDA approval for interchangeable biosimilar Ranibizumab

Ranluspec is the only interchangeable ranibizumab biosimilar approved in the United States in both vial and pre-filled syringe (PFS) presentations

GVRP, Steps Biosciences launch dedicated formulations R&D Centre in Bengaluru

The facility integrates advanced scientific infrastructure and specialised workflows to support complex drug delivery systems, sterile injectables, and differentiated dosage forms

CII appoints Manni Kantipudi and Manoj Kumar R. Panicker to lead CRDMO task force

Industry body aims to strengthen policy advocacy, innovation, and global competitiveness of India's fast-growing CRDMO sector

Dr. Rajesh Jain appointed chairman of CII National Committee on Biotechnology

Dr. Jain brings extensive experience in the biotech and pharma sectors and has been instrumental in driving innovation, vaccine development, and healthcare advancement

Aragen Life Sciences elevates Pavan Kumar Kamarajugadda to Senior Director